Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5WOD

De Novo Design of Covalently Constrained Meso-size Protein Scaffolds with Unique Tertiary Structures

5WOD の概要
エントリーDOI10.2210/pdb5wod/pdb
NMR情報BMRB: 30320
分子名称38-mer peptide (1 entity in total)
機能のキーワードde novo design, covalent constrained peptide, de novo protein
由来する生物種synthetic construct
タンパク質・核酸の鎖数1
化学式量合計4058.44
構造登録者
Wu, H.,Wu, Y.,DeGrado, W.F. (登録日: 2017-08-01, 公開日: 2017-10-04, 最終更新日: 2024-05-15)
主引用文献Dang, B.,Wu, H.,Mulligan, V.K.,Mravic, M.,Wu, Y.,Lemmin, T.,Ford, A.,Silva, D.A.,Baker, D.,DeGrado, W.F.
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures.
Proc. Natl. Acad. Sci. U.S.A., 114:10852-10857, 2017
Cited by
PubMed Abstract: The folding of natural proteins typically relies on hydrophobic packing, metal binding, or disulfide bond formation in the protein core. Alternatively, a 3D structure can be defined by incorporating a multivalent cross-linking agent, and this approach has been successfully developed for the selection of bicyclic peptides from large random-sequence libraries. By contrast, there is no general method for the de novo computational design of multicross-linked proteins with predictable and well-defined folds, including ones not found in nature. Here we use Rosetta and Tertiary Motifs (TERMs) to design small proteins that fold around multivalent cross-linkers. The hydrophobic cross-linkers stabilize the fold by macrocyclic restraints, and they also form an integral part of a small apolar core. The designed CovCore proteins were prepared by chemical synthesis, and their structures were determined by solution NMR or X-ray crystallography. These mesosized proteins, lying between conventional proteins and small peptides, are easily accessible either through biosynthetic precursors or chemical synthesis. The unique tertiary structures and ease of synthesis of CovCore proteins indicate that they should provide versatile templates for developing inhibitors of protein-protein interactions.
PubMed: 28973862
DOI: 10.1073/pnas.1710695114
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 5wod
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon